🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
17Score
DipBuster Score™
$237.28
+$3.18 (+1.36%)
Live price · Source: Yahoo
52-Week Position
$101.00
98% of range
$239.64
Beta
0.882
Market-like
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.882
52W High$239.64
52W Low$101.00
DipBuster Brief
Key signals at a glance
Zone: Sell / Avoid
Bearish
Near 52-Week High — Asymmetric Risk
At 98% of its annual range the stock is close to its peak. New buyers face limited upside and meaningful downside if sentiment shifts.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position98% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.882
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at DaVita Inc. (DVA), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-06-16 | Rodriguez Javier | SELL | 39,407 |
| 2026-06-15 | Waters Kathleen Alyce | SELL | 6,455 |
| 2026-06-15 | Waters Kathleen Alyce | SELL | 8,950 |
| 2026-06-15 | Rodriguez Javier | SELL | 30,000 |
| 2026-05-26 | Yale Phyllis R | SELL | 5,038 |
| 2026-05-15 | Pullin Dennis W | BUY | 250 |
| 2026-05-15 | Moore Gregory J. | BUY | 250 |
| 2026-05-15 | Hearty James O | SELL | 15,000 |
| 2026-05-15 | Hollar Jason M. | BUY | 250 |
| 2026-05-15 | Arway Pamela M | BUY | 250 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.882
Dividend/yrNone
52W High$239.64
52W Low$101.00
52-Week Range
$101.00Now$239.64
98% through annual range
From 52W High−1%
From 52W Low+134.9%
📖 Plain English Summary
DaVita Inc. is at 98% of its 52-week range. Beta 0.882 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for DVA
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — DVA
Heuristic · balance sheet, insider filings, price data, academic research
DaVita Inc. — DipBuster Score 17/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track DaVita Inc. free
Add DVA to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
1/25
Momentum & Volume
11/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
0
/100 · NEUTRAL
dip depth
0/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 17/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpati…
Sector
Healthcare
Market
🇺🇸 US
CEO
Javier J. Rodriguez
Staff
78,000 employees
Website